<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

TCL Archive

Researchers Link Cancer Risk And DMPA Birth Control Use

Breast-Conserving Procedures Lead To Frequent Follow-up Care

False-Positive Mammograms Can Indicate Higher Cancer Risk

Proposed Surveillance Model Aims To Reduce Post-Treatment Pain

Adding Avastin Did Not Improve Standard Chemotherapy Regimen

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

Translplants Not Best Choice in Subset of ALL Patients

PET Response Can Predict Increased Survival In Patients